Rock Springs Capital Management LP 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:01 pm Sale |
2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 0 0.000% |
-2,581,299 (Position Closed) |
Filing |
| 2022-02-14 6:24 pm Purchase |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 2,581,299 5.370% |
1,266,925 (+96.39%) |
Filing |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 1,314,374 4.480% |
-337,500 (-20.43%) |
Filing |
| 2020-11-16 4:59 pm Purchase |
2020-11-06 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 1,651,874 5.630% |
526,874 (+46.83%) |
Filing |